chr9-101573485-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_133445.3(GRIN3A):c.3037G>A(p.Val1013Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,613,930 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133445.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIN3A | NM_133445.3 | c.3037G>A | p.Val1013Ile | missense_variant | 9/9 | ENST00000361820.6 | NP_597702.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIN3A | ENST00000361820.6 | c.3037G>A | p.Val1013Ile | missense_variant | 9/9 | 1 | NM_133445.3 | ENSP00000355155.3 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251012Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135642
GnomAD4 exome AF: 0.000241 AC: 353AN: 1461708Hom.: 2 Cov.: 32 AF XY: 0.000241 AC XY: 175AN XY: 727158
GnomAD4 genome AF: 0.000263 AC: 40AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.3037G>A (p.V1013I) alteration is located in exon 9 (coding exon 9) of the GRIN3A gene. This alteration results from a G to A substitution at nucleotide position 3037, causing the valine (V) at amino acid position 1013 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at